Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice (Q43180173)

15 November 2017

Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice (English)

1 reference

non-alcoholic steatohepatitis

15 November 2017

0 references

1 reference

1 reference

3

1 reference

15 November 2017

7

1 reference

15 November 2017

9

1 reference

15 November 2017

Kristiaan Wouters

1

0 references

author name string

Marc van Bilsen

2

1 reference

15 November 2017

Veerle Bieghs

4

1 reference

15 November 2017

Dieter Lütjohann

5

1 reference

15 November 2017

Anja Kerksiek

6

1 reference

15 November 2017

Marten H Hofker

8

1 reference

15 November 2017

language of work or name

English

0 references

publication date

29 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

584

1 reference

15 November 2017

1001-1005

1 reference

15 November 2017

5

1 reference

Fatty liver: a novel component of the metabolic syndrome

15 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Protein sensors for membrane sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Identification of a physiologically relevant endogenous ligand for PPARalpha in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

A lipidomic analysis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

LXR-dependent gene expression is important for macrophage survival and the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Coordinate control of intermediary metabolism in rat liver by the insulin/glucagon ratio during starvation and after glucose refeeding. Regulatory significance of long-chain acyl-CoA and cyclic AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.01.046

Analysis of the in vivo functions of Mrp3.

21 January 2018

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.FEBSLET.2010.01.046

Identifiers

DOI

10.1016/J.FEBSLET.2010.01.046

1 reference

release_k76ucl2ws5hc3ofjcttkozb5ji

15 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k76ucl2ws5hc3ofjcttkozb5ji

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference